Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia

Blood Adv. 2020 Sep 22;4(18):4358-4361. doi: 10.1182/bloodadvances.2020002745.

Abstract

  1. Standard chemotherapy can still be used for new diagnosis of acute lymphoblastic leukemia in patients with SARS-CoV-2.

  2. Corticosteroid can be given safely to patients with SARS-CoV-2 presenting with acute respiratory distress syndrome and ALL.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Allopurinol / therapeutic use
  • Anemia, Hemolytic, Autoimmune / etiology
  • Anti-Bacterial Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Betacoronavirus*
  • COVID-19
  • Combined Modality Therapy
  • Coronavirus Infections / complications*
  • Coronavirus Infections / diagnostic imaging
  • Cytokine Release Syndrome / etiology
  • Daunorubicin / administration & dosage
  • Fluid Therapy
  • Humans
  • Male
  • Methylprednisolone / therapeutic use
  • Nitriles
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / diagnostic imaging
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / complications*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Pyrazoles / therapeutic use
  • Pyrimidines
  • Respiration, Artificial
  • Respiratory Distress Syndrome / diagnostic imaging
  • Respiratory Distress Syndrome / drug therapy
  • Respiratory Distress Syndrome / etiology*
  • Respiratory Distress Syndrome / therapy
  • SARS-CoV-2
  • Vincristine / administration & dosage

Substances

  • Anti-Bacterial Agents
  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • Vincristine
  • Allopurinol
  • ruxolitinib
  • Methylprednisolone
  • Daunorubicin